相关实验视频
Updated: Jan 13, 2026
08:53
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
Published on: March 28, 2025
772
材料诱导的血小板粘附/激活和血液溶解膜肺部组件从体外膜氧化
Christopher Thaus1, Matthias Lubnow2, Lars Krenkel3
1Department of Cardiothoracic Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Biomedicines
|October 29, 2025
概括
在体外膜氧化 (ECMO) 过程中血小板对膜肺材料的粘附因表面涂层而有所不同. 采用X.ELLENCE涂层的纤维显示血小板粘附率明显较高,需要进一步进行血红相容性测试.
科学领域:
- 生物材料科学 生物材料科学
- 医疗设备工程 医疗设备工程
- 血液学 血液学 血液学
背景情况:
- 血液与膜肺 (MLs) 中的人造表面的接触可以在体外膜氧化 (ECMO) 期间引起器械血栓.
- 了解材料的血红相容性对于ECMO设备的安全性和有效性至关重要.
研究的目的:
- 评估不同膜肺材料的血液相容性,重点关注血小板粘附和激活.
- 将血小板相互作用与气体交换纤维 (GF) 和热交换纤维 (HE) 上的各种表面涂层进行比较.
主要方法:
- 商业ML的血液相容性测试,包括静态血液溶解和血小板粘附/激活试验.
- 使用流细胞计量来量化血小板激活和染色后的表面覆盖.
主要成果:
- 所有测试材料都是非溶血性的,并没有诱导血小板激活.
- 与其他涂层GF相比,未涂层GF和X.ELLENCE涂层GF (Hilite-ML) 的血小板粘附率显著更高.
- 采用X.ELLENCE涂层的热交换纤维 (Hilite-ML) 的血小板覆盖率也高于采用Balance涂层的HE.
结论:
- 在体外测试显示,与其他ECMO材料相比,X.ELLENCE涂层的Hilite-ML的GF和HE的血小板粘附率增加了四倍.
- 需要进行额外的血红相容性研究,以充分评估增加血小板粘附对Hilite-ML成分的影响.
相关概念视频
01:22Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K
01:05Introduction to Hemostasis
13.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.2K